Cell Medica buys T cell receptor cancer candidate from UK Catapult
Cell Medica says it will work with the Cell and Gene Therapy Catapult to assess automation and processing technologies involved in scaling-up the acquired cancer candidate.
Archives for June 19, 2017
Single-use in Ireland on the up? GE Healthcare, Thermo Fisher and NIBRT discuss the trend
Ireland’s “thriving biopharma industry” has traditionally employed large-scale bioreactors, however a new wave of biologics with changing production requirements is changing the trend, say industry representatives.
TxCell hires Lentigen to make vectors used to produce its organ rejection cell therapy
TxCell SA has hired Lentigen Technology Inc. to make the vectors it uses to make its T-cell transplant rejection therapy.